stated Mr. Ronghua Wang
, Chairman and Chief Executive Officer of Biostar.
"His strong financial background and extensive investment experience, in
addition to his bilingual skills and bicultural background, will strengthen
our capabilities in the execution of our growth strategy, financial management
and corporate communications. We are confident that the new appointment will
help create a stronger organization and facilitate our future growth."
About Biostar Pharmaceuticals, Inc.
Biostar Pharmaceuticals, Inc., through its wholly-owned subsidiary in
China, develops, manufactures and markets pharmaceutical products for a
variety of diseases and conditions. The Company's most popular product is its
Xin-Aoxing Oleanolic Acid Capsule, an over-the-counter ("OTC") medicine for
chronic hepatitis B, a disease affecting approximately 10% of the Chinese
population. In addition to its hepatitis product, Biostar currently
manufactures two broad-based OTC products and two prescription-based
pharmaceuticals. The Company has adopted international standards, holds one
patent and is in the process of applying for two patents.
Certain statements in this release concerning our future growth prospects
are forward-looking statements, within the meaning of Section 27A of the U.S.
Securities Act of 1933, as amended, and Section 21E of the U.S. Securities
Exchange Act of 1934, as amended, which involve a number of risks and
uncertainties that could cause actual results to differ materially from those
in such forward-looking statements. The risks and uncertainties relating to
these statements include, but are not limited to, risks and uncertainties
regarding the success of our investments, risks and uncertainties regarding
fluctuations in earnings, o
Page: 1 2 3 Related biology technology :1
|SOURCE Biostar Pharmaceuticals, Inc.|
Copyright©2010 PR Newswire.
All rights reserved
. Biostar Pharmaceuticals, Inc. Begins Assembly of New Production Line2
. Biostar Pharmaceuticals, Inc. Announces First Quarter 2010 Financial Results3
. Biostar Pharmaceuticals, Inc. to Launch Xin Aoxing Oleanolic Acid Capsules in Beijing and Shanghai4
. Biostar Pharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results5
. Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Friday, August 14, 2009 at 10:30 a.m. EDT6
. Biostar Pharmaceuticals, Inc. Retains HC International, Inc. to Implement Investor Relations Program7
. Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 20098
. Biostar Pharmaceuticals, Inc. Reports Record Revenues and Earnings for 20089
. Inverness Medical Innovations to Close Cholestech, HemoSense and BioStar Facilities10
. Melissa Kemp, Ph.D., Wins the Council for Systems Biology in Boston (CSB2) Award Sponsored by Merrimack Pharmaceuticals, Inc.11
. INTUNIV(TM) - Shire Files Suit Against Anchen Pharmaceuticals, Inc. and Anchen, Inc.